Aptevo Therapeutics Inc. held its 2025 Annual Meeting of Stockholders on July 24, 2025. The election of Marvin L. White and John E Niederhuber, M.D. to the Board of Directors was approved. The appointment of Baker Tilly US, LLP as the independent registered public accounting firm for 2025 was ratified. An amendment to the Company's Amended and Restated Certificate of Incorporation to effect a reverse stock split was approved. The issuance of more than 19.99% of the Company's outstanding Common Stock was approved. Authorization to adjourn the Special Meeting to a later date was approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.